248 related articles for article (PubMed ID: 33125094)
1. p53 and ANXA4/NF‑κB p50 complexes regulate cell proliferation, apoptosis and tumor progression in ovarian clear cell carcinoma.
Liu J; Wang H; Zheng M; Deng L; Zhang X; Lin B
Int J Mol Med; 2020 Dec; 46(6):2102-2114. PubMed ID: 33125094
[TBL] [Abstract][Full Text] [Related]
2. Annexin A4 interacts with the NF-kappaB p50 subunit and modulates NF-kappaB transcriptional activity in a Ca2+-dependent manner.
Jeon YJ; Kim DH; Jung H; Chung SJ; Chi SW; Cho S; Lee SC; Park BC; Park SG; Bae KH
Cell Mol Life Sci; 2010 Jul; 67(13):2271-81. PubMed ID: 20237821
[TBL] [Abstract][Full Text] [Related]
3. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.
Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B
Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907
[TBL] [Abstract][Full Text] [Related]
4. Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.
Mogami T; Yokota N; Asai-Sato M; Yamada R; Koizume S; Sakuma Y; Yoshihara M; Nakamura Y; Takano Y; Hirahara F; Miyagi Y; Miyagi E
PLoS One; 2013; 8(11):e80359. PubMed ID: 24244679
[TBL] [Abstract][Full Text] [Related]
5. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.
Takaya A; Peng WX; Ishino K; Kudo M; Yamamoto T; Wada R; Takeshita T; Naito Z
Int J Oncol; 2015 Apr; 46(4):1573-81. PubMed ID: 25633807
[TBL] [Abstract][Full Text] [Related]
6. Annexin A4 and cancer.
Wei B; Guo C; Liu S; Sun MZ
Clin Chim Acta; 2015 Jul; 447():72-8. PubMed ID: 26048190
[TBL] [Abstract][Full Text] [Related]
7. Annexin A4 fucosylation enhances its interaction with the NF-kB p50 and promotes tumor progression of ovarian clear cell carcinoma.
Wang H; Deng L; Cai M; Zhuang H; Zhu L; Hao Y; Gao J; Liu J; Li X; Lin B
Oncotarget; 2017 Dec; 8(64):108093-108107. PubMed ID: 29296226
[TBL] [Abstract][Full Text] [Related]
8. ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer.
Li L; Zhang R; Liu Y; Zhang G
DNA Cell Biol; 2020 Sep; 39(9):1649-1656. PubMed ID: 32552056
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of RALYL suppresses the progression of ovarian clear cell carcinoma through inhibiting MAPK and CDH1 signaling pathways.
Xia Y; Ye S; Yang Y; Liu Y; Tong G
Int J Med Sci; 2021; 18(3):785-791. PubMed ID: 33437214
[No Abstract] [Full Text] [Related]
10. Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arrays.
Lin LL; Huang HC; Juan HF
PLoS One; 2012; 7(9):e44615. PubMed ID: 22970268
[TBL] [Abstract][Full Text] [Related]
11. Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer.
Yao HS; Sun C; Li XX; Wang Y; Jin KZ; Zhang XP; Hu ZQ
Sci Rep; 2016 Aug; 6():31056. PubMed ID: 27491820
[TBL] [Abstract][Full Text] [Related]
12. The involvement of SIRT1 and transcription factor NF-κB (p50/p65) in regulation of porcine ovarian cell function.
Pavlová S; Klucska K; Vašíček D; Ryban L; Harrath AH; Alwasel SH; Sirotkin AV
Anim Reprod Sci; 2013 Aug; 140(3-4):180-8. PubMed ID: 23886618
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.
Ota Y; Koizume S; Nakamura Y; Yoshihara M; Takahashi T; Sato S; Myoba S; Ohtake N; Kato H; Yokose T; Miyagi E; Miyagi Y
Oncol Rep; 2021 Mar; 45(3):1023-1032. PubMed ID: 33650653
[TBL] [Abstract][Full Text] [Related]
15. The role of annexin A4 in cancer.
Yao H; Sun C; Hu Z; Wang W
Front Biosci (Landmark Ed); 2016 Jun; 21(5):949-57. PubMed ID: 27100483
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between sirtuin 1 and transcription factors p53 and NF-κB (p50/p65) in the control of ovarian cell apoptosis and proliferation.
Sirotkin AV; Dekanová P; Harrath AH; Alwasel SH; Vašíček D
Cell Tissue Res; 2014 Nov; 358(2):627-32. PubMed ID: 25027053
[TBL] [Abstract][Full Text] [Related]
17. Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers.
Toyama A; Suzuki A; Shimada T; Aoki C; Aoki Y; Umino Y; Nakamura Y; Aoki D; Sato TA
Cancer Sci; 2012 Apr; 103(4):747-55. PubMed ID: 22321069
[TBL] [Abstract][Full Text] [Related]
18. The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma.
Oishi T; Itamochi H; Kudoh A; Nonaka M; Kato M; Nishimura M; Oumi N; Sato S; Naniwa J; Sato S; Shimada M; Kigawa J; Harada T
Oncol Rep; 2014 Aug; 32(2):553-8. PubMed ID: 24927217
[TBL] [Abstract][Full Text] [Related]
19. ANXA4 promotes trophoblast invasion via the PI3K/Akt/eNOS pathway in preeclampsia.
Xu Y; Sui L; Qiu B; Yin X; Liu J; Zhang X
Am J Physiol Cell Physiol; 2019 Apr; 316(4):C481-C491. PubMed ID: 30673304
[TBL] [Abstract][Full Text] [Related]
20. Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma.
Mehner C; Miller E; Hockla A; Coban M; Weroha SJ; Radisky DC; Radisky ES
Oncogene; 2020 Oct; 39(42):6606-6618. PubMed ID: 32929152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
